We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Anticancer Therapies – Multimedia

Drug–Target Binding: Recent Research Developments content piece image
Listicle

Drug–Target Binding: Recent Research Developments

Being able to accurately predict drug–target interactions (DTIs) and drug–target binding affinity (DTBA) is crucial in early drug development and during drug repurposing endeavors. Here, we look at some recent research developments in this space.
Breast Cancer Treatment – Prof. Andrew Tutt on the OlympiA Trial content piece image
Video

Breast Cancer Treatment – Prof. Andrew Tutt on the OlympiA Trial

The results of the OlympiA clinical trial, involving ICR researchers, shows giving the drug olaparib for one year to breast cancer patients with inherited BRCA mutations, after they have completed initial treatment, reduced the chance of their breast cancer returning. Professor Andrew Tutt, Head of Breast Cancer Research at the ICR, explains more.
Key Developments in Cancer Immunotherapy Over the Last Decade content piece image
Listicle

Key Developments in Cancer Immunotherapy Over the Last Decade

Download this list to explore current immunotherapeutic strategies, recent regulatory approvals and the future of cancer therapy.
Advances in Cell Microscopy content piece image
Listicle

Advances in Cell Microscopy

Since the earliest microscopy efforts in the 1600s, cell imaging has significantly modernized and become a ubiquitous tool in cell biology laboratories. Here, we cover five key advances in cell microscopy to help you understand how the field is progressing.
Key Techniques in Cell Therapy Quality Control content piece image
Listicle

Key Techniques in Cell Therapy Quality Control

Download this list to discover more about some of the latest key techniques in cell therapy quality control.
TSE Explores Cancer Research – The Future of Cancer Research content piece image
Video

TSE Explores Cancer Research – The Future of Cancer Research

In this episode we will be speaking with Professor Bissan Al-Lazikani, from the Institute of Cancer Research about how data science and machine learning approaches are used for cancer drug discovery and treatment adaptation.
CAR T Cells: A Living Targeted Drug, With Dr Matt Cooper content piece image
Video

CAR T Cells: A Living Targeted Drug, With Dr Matt Cooper

In this installment of Teach Me in 10, we're joined by Matt Cooper, co-founder and chief scientific officer at Wugen, Inc. He is also assistant professor of medicine at Washington University. Matt discusses what T cells are and how they can be engineered to recognize cancer cells.
Antibody Detection for Cancer Research content piece image
eBook

Antibody Detection for Cancer Research

Cancer cells predominantly evade the immune system in two ways – they prevent immune cells from detecting them and they deactivate immune responses prematurely. Download this eBook to discover an antibody multiplexing technique
Opinionated Science Episode 21: The Roundup – Moon Phases, Anti-Cancer Elephants and Poop Infusions content piece image
Podcast

Opinionated Science Episode 21: The Roundup – Moon Phases, Anti-Cancer Elephants and Poop Infusions

In this episode, the TN team rounds up some of the best and weirdest science from the last month. Hear how elephants and naked mole rats fight cancer, how immunotherapy is getting a microbial boost from poop transplants and why researchers think our sleep patterns might be affected by the phases of the moon.
Interrogation and Modulation of the Immunosuppressive Activity of Human TAM-Like Macrophages Using <i>In Vitro</i> Cultures content piece image
Poster

Interrogation and Modulation of the Immunosuppressive Activity of Human TAM-Like Macrophages Using In Vitro Cultures

Tumor associated macrophages (TAMs) can facilitate the proliferation of tumor cells and are able to suppress anti-tumor immune responses within the tumor microenvironment, making them a highly attractive target for the development of innovative cancer immunotherapies.
Advertisement